Cadrenal Therapeutics, Inc. (CVKD): Total Assets
$4.33M
As of 2025-12-31
$5.59M
As of 2026-06-30
+77.2%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.33M | -57.3% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $10.12M | +18.8% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $8.52M | +994.8% | 2025-03-13, Balance as of period end |
| 2022-12-31 | $778.2K | n/a | 2024-03-11, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Cadrenal Therapeutics, Inc. (CVKD) | 2025-12-31 | $4.33M | -57.3% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $4.18M | -52.9% |
| Pulmatrix, Inc. (PULM) | 2025-12-31 | $4.14M | -58.4% |
| International Stem Cell Corp (ISCO) | 2025-12-31 | $4.82M | -6.8% |
| Bio-Path Holdings, Inc. (BPTH) | 2024-12-31 | $3.88M | +20.6% |
| Azitra, Inc. (AZTR) | 2025-12-31 | $5.03M | -31.7% |
| Enveric Biosciences, Inc. (ENVB) | 2025-12-31 | $5.10M | +65.3% |
| Protagenic Therapeutics, Inc.\new (PTIX) | 2026-03-31 | $3.65M | n/m |
| Petros Pharmaceuticals, Inc. (PTPI) | 2025-12-31 | $5.16M | -51.4% |
Compare CVKD, LEXX, PULM, ISCO side by side · Screen every company in Pharmaceutical Preparations ↗